Clinical Study

Ovarian Reserve in Women Treated for Acute Lymphocytic Leukemia or Acute Myeloid Leukemia with Chemotherapy, but Not Stem Cell Transplantation

Table 3

Ovarian reserve markers in the leukemia and comparison groups.

GroupSubject Age (years)Follicle stimulating hormone (mIU/mL)Estradiol (pg/mL)AMH (ng/mL)Inhibin B (pg/mL)Antral follicle countOvarian volume (cm3)

L13915.720.20.0545.371.8
C13871.275.6<0.0229.367.3

L2336.296.51.8718.9134.7
C2345.432.23.568.62811.8

L33315.624.6<0.0211639.6
C3345.027.64.457.9193.6

L42710.028.81.8636.5121.8
C4279.133.62.884.8177.6

L5257.737.20.6923.9144.1
C5268.844.63.14114207.3

LMedian (Range)10.0
(6.2–15.7)
28.8
(20.2–96.5)
0.69
(0.02–1.87)
36.5
(18.9–116)
12
(3–14)
4.1
(1.8–9.6)
CMedian (range)8.8
(5.0–71.2)
33.6
(32.2–75.6)
3.5
(0.02–4.4)
68.6
(29.3–114)
19
(6–28)
7.3
(3.6–11.8)

L: leukemia group; C: comparison group. Matched subjects have the same number. Ovarian volume is the average volume of the right and left ovary.